Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | ACP3 | P15309 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.43 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.43 |
| ▸ | NQO2 | P16083 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2325052 | 0.88 | HPRT1 (0.52) | CYP1A2CYP2C19CYP2C9TDP1ACP3 | |
| SCHEMBL1611986 | 0.83 | CYP1A2 (0.52) | CYP1A2CYP2C19CYP2C9TDP1ACP3 | |
| SCHEMBL2858432 | 0.82 | CYP1A2 (0.56) | CYP1A2CYP2C19CYP2C9TDP1ACP3 | |
| SCHEMBL2858430 | 0.82 | CYP1A2 (0.56) | CYP1A2CYP2C19CYP2C9TDP1ACP3 | |
| SCHEMBL2326627 | 0.82 | ALDH1A1 (0.42) | CYP1A2CYP2C19CYP2C9TDP1ACP3 | |
| SCHEMBL143127 | 0.80 | MTNR1A (0.46) | CYP1A2CYP2C19CYP2C9TDP1ACP3 | |
| SCHEMBL143457 | 0.79 | MTNR1A (0.49) | CYP1A2CYP2C19CYP2C9TDP1ACP3 | |
| SCHEMBL182660 | 0.78 | CYP1A2 (0.52) | CYP1A2CYP2C19CYP2C9TDP1ACP3 | |
| SCHEMBL6176844 | 0.78 | CYP1A2 (0.52) | CYP1A2CYP2C19CYP2C9TDP1ACP3 | |
| SCHEMBL7033804 | 0.78 | CYP1A2 (0.57) | CYP1A2CYP2C19CYP2C9TDP1ACP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2296 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240158441-A1 | BRANCHED PEPTIDES FOR ENZYMATIC ASSEMBLY AND MITOCHONDRIA DRUG DELIVERY | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-05-16 | — | — | US | claimed |
| CN-118021978-A | GHRH antagonists for use in methods of treating sarcoidosis | 迈阿密大学 | 2024-05-14 | — | — | CN | claimed |
| EP-4331674-A2 | GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS | University of Miami (US) | 2024-03-06 | — | — | EP | claimed |
| US-20240051992-A1 | THIOPHOSPHOPEPTIDES FOR ULTRAFAST TARGETING OF THE GOLGI APPARATUS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-02-15 | — | — | US | claimed |
| US-11839661-B2 | Rapid formation of supramolecular hydrogels by short peptide and bioactive small molecules | BRANDEIS UNIVERSITY (US) | 2023-12-12 | — | — | US | claimed |
| US-11834517-B2 | Branched peptides for enzymatic assembly and mitochondria drug delivery | BRANDEIS UNIVERSITY (US) | 2023-12-05 | — | — | US | claimed |
| EP-3999095-B1 | GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS | UNIV MIAMI (US) | 2023-09-13 | — | — | EP | claimed |
| CN-116003323-A | Fluorine-containing pyrazole phenylacetamide derivative and application thereof | 西北农林科技大学 | 2023-04-25 | — | — | CN | claimed |
| WO-2022271798-A1 | ENZYMATICALLY FORMING INTRANUCLEAR PEPTIDE ASSEMBLIES FOR SELECTIVELY KILLING INDUCED PLURIPOTENT STEM CELLS | BRANDEIS UNIVERSITY (US) | 2022-12-29 | — | — | WO | claimed |
| CN-115515617-A | Diamine-linked receptor-specific cyclic peptides | 帕拉丁科技公司 | 2022-12-23 | — | — | CN | claimed |
| EP-0315367-A2 | Polypeptides | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1989-05-10 | — | — | EP | claimed |
| US-4804650-A | DIURETICS, VASODILATORS | BIOTECHNOLOGY RESEARCH ASSOCIATES, J.V. (US) | 1989-02-14 | — | — | US | claimed |
| EP-0237082-A2 | 3,5-disubstituted 4,5-dihydroisoxazoles as transglutaminase inhibitors | SYNTEX (U.S.A.) INC. (US) | 1987-09-16 | — | — | EP | claimed |
| EP-0223143-A2 | Analogs of atrial natriuretic peptides | CALIFORNIA BIOTECHNOLOGY, INC. (US) | 1987-05-27 | — | — | EP | claimed |
| WO-1987002674-A1 | ANALOGS OF ATRIAL NATRIURETIC PEPTIDES | BIOTECHNOLOGY RESEARCH ASSOCIATES, J.V. (US) | 1987-05-07 | — | — | WO | claimed |
| US-4269773-A | CEPHALOSPORINS | SHIONOGI & CO., LTD. (JP) | 1981-05-26 | — | — | US | claimed |
| US-4267340-A | BACTERICIDES; SYNTHESIS OF PENICILLINS AND CEPHALOSPORINS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-05-12 | — | — | US | claimed |
| US-4092474-A | Cephalosporins having a metaloxy group in 3-substituent | SHIONOGI & CO., LTD. (JA) | 1978-05-30 | — | — | US | claimed |
| US-4009159-A | PENICILLINS | FUJISAWA PHARMACEUTICAL CO., LTD. (JA) | 1977-02-22 | — | — | US | claimed |
| US-3993646-A | Process for the ring expansion of penicillins to cephalosporin compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JA) | 1976-11-23 | — | — | US | claimed |